Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/133153
| Title: | Association of RNA-sequencing signatures with clinical outcomes of pembrolizumab plus chemotherapy in patients with metastatic nonsquamous non-small cell lung cancer (NSCLC) enrolled in the phase 2 KEYNOTE-782 trial. | Authors: | Felip, Enriqueta Aix, Santiago Ponce Bar, Jair Esteban, Emilio Rodríguez Abreu, Delvys Csoszi, Tibor Gottfried, Maya Szalai, Zsuzsanna Provencio, Mariano Fulop, Andrea Rao, Suman Camidge, David Ross Speranza, Giovanna Pruitt, Scott K. Townson, Steven Matthew Kobie, Julie Dettman, E. J. Loboda, Andrey Nebozhyn, Michael Robinson, Andrew George |
UNESCO Clasification: | 320101 Oncología 320508 Enfermedades pulmonares |
Issue Date: | 2023 | Journal: | Journal of Clinical Oncology | URI: | http://hdl.handle.net/10553/133153 | ISSN: | 0732-183X | Source: | Journal Of Clinical Oncology [ISSN 0732-183X], v. 42 (16) sup. S, Abstract 8578, (Junio 2024). |
| Appears in Collections: | Actas de congresos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.